atc_level_01_code,atc_level_01_name,atc_level_02_code,atc_level_02_name,atc_level_03_code,atc_level_03_name,atc_level_04_code,atc_level_04_name,atc_level_04_note,atc_level_05_code,atc_level_05_name,atc_level_05_note,DDD_O,DDD_P,DDD_R,unit_O,unit_P,unit_R
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,Butylpyrazolidines,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AA01,phenylbutazone,NA,0.3,0.3,0.3,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,Butylpyrazolidines,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AA02,mofebutazone,NA,0.75,0.75,NA,g,g,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,Butylpyrazolidines,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AA03,oxyphenbutazone,NA,0.3,NA,0.3,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,Butylpyrazolidines,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AA05,clofezone,NA,0.6,NA,0.6,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,Butylpyrazolidines,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AA06,kebuzone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB01,indometacin,NA,0.1,0.1,0.1,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB02,sulindac,NA,0.4,0.4,0.4,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB03,tolmetin,NA,0.7,NA,0.7,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB04,zomepirac,NA,0.3,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB05,diclofenac,NA,0.1,0.1,0.1,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB06,alclofenac,NA,1.25,NA,1.25,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB07,bumadizone,NA,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB08,etodolac,NA,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB09,lonazolac,NA,0.6,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB10,fentiazac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB11,acemetacin,NA,0.12,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB12,difenpiramide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB13,oxametacin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB14,proglumetacin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB15,ketorolac,NA,30,30,NA,mg,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB16,aceclofenac,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB17,bufexamac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB51,"indometacin, combinations",Refers to indometacin,0.1,NA,0.1,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AB55,"diclofenac, combinations",Refers to diclofenac,0.1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC01,piroxicam,NA,20,20,20,mg,mg,mg
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC02,tenoxicam,NA,20,20,20,mg,mg,mg
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC04,droxicam,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC05,lornoxicam,NA,12,12,12,mg,mg,mg
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC06,meloxicam,NA,15,15,15,mg,mg,mg
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,Oxicams,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for meloxicam is based on the treatment of osteoarthritis.",M01AC56,"meloxicam, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE01,ibuprofen,NA,1.2,1.2,1.2,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE02,naproxen,NA,0.5,NA,0.5,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE03,ketoprofen,NA,0.15,0.15,0.15,g,g,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE04,fenoprofen,NA,1.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE05,fenbufen,NA,0.6,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE06,benoxaprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE07,suprofen,NA,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE08,pirprofen,NA,0.8,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE09,flurbiprofen,NA,0.2,NA,0.2,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE10,indoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE11,tiaprofenic acid,NA,0.6,NA,0.6,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE12,oxaprozin,NA,0.9,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE13,ibuproxam,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE14,dexibuprofen,NA,0.8,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE15,flunoxaprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE16,alminoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE17,dexketoprofen,NA,75,75,NA,mg,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE18,naproxcinod,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE51,"ibuprofen, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE52,naproxen and esomeprazole,Refers to naproxen,0.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE53,"ketoprofen, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE56,naproxen and misoprostol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,Propionic acid derivatives,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AE57,naproxen and diphenhydramine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,Fenamates,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AG01,mefenamic acid,NA,1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,Fenamates,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AG02,tolfenamic acid,NA,0.3,NA,0.3,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,Fenamates,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AG03,flufenamic acid,NA,0.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,Fenamates,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).",M01AG04,meclofenamic acid,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH01,celecoxib,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH02,rofecoxib,NA,25,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH03,valdecoxib,NA,10,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH04,parecoxib,NA,NA,40,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH05,etoricoxib,NA,60,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH06,lumiracoxib,NA,0.1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,"The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDDs for the coxibs are based on the treatment of osteoarthritis.",M01AH07,polmacoxib,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX01,nabumetone,NA,1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX02,niflumic acid,NA,0.75,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX04,azapropazone,NA,0.75,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX05,glucosamine,Refers to glucosamine sulfate,1.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX07,benzydamine,NA,0.15,NA,0.15,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX12,glucosaminoglycan polysulfate,NA,NA,50,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX13,proquazone,NA,0.9,NA,0.9,g,NA,g
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX14,orgotein,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX17,nimesulide,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX18,feprazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX21,diacerein,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX22,morniflumate,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX23,tenidap,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX24,oxaceprol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX25,chondroitin sulfate,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX26,"avocado and soyabean oil, unsaponifiables",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids","The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH). The DDD for glucosamine refers to glucosamine sulfate.",M01AX68,"feprazone, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01B,ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION,M01BA,Antiinflammatory/antirheumatic agents in combination with corticosteroids,NA,M01BA01,phenylbutazone and corticosteroids,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01B,ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION,M01BA,Antiinflammatory/antirheumatic agents in combination with corticosteroids,NA,M01BA02,dipyrocetyl and corticosteroids,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01B,ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION,M01BA,Antiinflammatory/antirheumatic agents in combination with corticosteroids,NA,M01BA03,acetylsalicylic acid and corticosteroids,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01B,ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION,M01BX,Other antiinflammatory/antirheumatic agents in combination with other drugs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CA,Quinolines,The DDDs are based on the treatment of rheumatoid arthritis.,M01CA03,oxycinchophen,NA,1.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,The DDDs are based on the treatment of rheumatoid arthritis.,M01CB01,sodium aurothiomalate,NA,NA,2.4,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,The DDDs are based on the treatment of rheumatoid arthritis.,M01CB02,sodium aurotiosulfate,NA,NA,14,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,The DDDs are based on the treatment of rheumatoid arthritis.,M01CB03,auranofin,NA,6,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,The DDDs are based on the treatment of rheumatoid arthritis.,M01CB04,aurothioglucose,NA,NA,2.4,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,The DDDs are based on the treatment of rheumatoid arthritis.,M01CB05,aurotioprol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CC,Penicillamine and similar agents,The DDDs are based on the treatment of rheumatoid arthritis.,M01CC01,penicillamine,NA,0.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CC,Penicillamine and similar agents,The DDDs are based on the treatment of rheumatoid arthritis.,M01CC02,bucillamine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CX,Other specific antirheumatic agents,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA01,phenylbutazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA02,mofebutazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA03,clofezone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA04,oxyphenbutazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA05,benzydamine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA06,etofenamate,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA07,piroxicam,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA08,felbinac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA09,bufexamac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA10,ketoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA11,bendazac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA12,naproxen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA13,ibuprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA14,fentiazac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA15,diclofenac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA16,feprazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA17,niflumic acid,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA18,meclofenamic acid,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA19,flurbiprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA21,tolmetin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA22,suxibuzone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA23,indometacin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA24,nifenazone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA25,aceclofenac,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA26,nimesulide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA27,dexketoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA28,piketoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA29,esflurbiprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",No DDDs have been assigned in this group.,M02AA31,loxoprofen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AB,Capsaicin and similar agents,No DDDs have been assigned in this group.,M02AB01,capsaicin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AB,Capsaicin and similar agents,No DDDs have been assigned in this group.,M02AB02,zucapsaicin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AC,Preparations with salicylic acid derivatives,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain,No DDDs have been assigned in this group.,M02AX02,tolazoline,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain,No DDDs have been assigned in this group.,M02AX03,dimethyl sulfoxide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain,No DDDs have been assigned in this group.,M02AX05,idrocilamide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain,No DDDs have been assigned in this group.,M02AX06,tolperisone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain,No DDDs have been assigned in this group.,M02AX10,various,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AA,Curare alkaloids,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AA01,alcuronium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AA,Curare alkaloids,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AA02,tubocurarine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AA,Curare alkaloids,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AA04,dimethyltubocurarine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AB,Choline derivatives,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AB01,suxamethonium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC01,pancuronium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC02,gallamine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC03,vecuronium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC04,atracurium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC05,hexafluronium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC06,pipecuronium bromide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC07,doxacurium chloride,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC08,fazadinium bromide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC09,rocuronium bromide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC10,mivacurium chloride,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,Other quaternary ammonium compounds,"As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AC11,cisatracurium,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AX,"Other muscle relaxants, peripherally acting agents","As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.",M03AX01,botulinum toxin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA01,phenprobamate,NA,1.6,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA02,carisoprodol,NA,1.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA03,methocarbamol,NA,3,3,NA,g,g,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA04,styramate,NA,0.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA05,febarbamate,NA,0.3,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA51,"phenprobamate, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA52,"carisoprodol, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA53,"methocarbamol, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA71,"phenprobamate, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA72,"carisoprodol, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,Carbamic acid esters,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BA73,"methocarbamol, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB02,chlormezanone,NA,0.6,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB03,chlorzoxazone,NA,1.5,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB52,"chlormezanone, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB53,"chlorzoxazone, combinations excl. psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB72,"chlormezanone, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BB73,"chlorzoxazone, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BC,"Ethers, chemically close to antihistamines","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BC01,orphenadrine (citrate),NA,0.12,0.12,NA,g,g,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BC,"Ethers, chemically close to antihistamines","These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BC51,"orphenadrine, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX01,baclofen,NA,50,0.55,NA,mg,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX02,tizanidine,NA,12,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX03,pridinol,NA,6,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX04,tolperisone,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX05,thiocolchicoside,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX06,mephenesin,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX07,tetrazepam,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX08,cyclobenzaprine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX09,eperisone,NA,0.15,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX30,fenyramidol,NA,2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX53,"pridinol, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents,"These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.DDDs for combination products, see list on the website www.whocc.no.",M03BX55,"thiocolchicoside, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M03,MUSCLE RELAXANTS,M03C,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",M03CA,Dantrolene and derivatives,The DDD of dantrolene is based on the treatment of spasticity after spinal injury.,M03CA01,dantrolene,NA,0.1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,The DDDs are based on prophylaxis.,M04AA01,allopurinol,NA,0.4,0.4,NA,g,g,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,The DDDs are based on prophylaxis.,M04AA02,tisopurine,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,The DDDs are based on prophylaxis.,M04AA03,febuxostat,NA,80,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,The DDDs are based on prophylaxis.,M04AA51,"allopurinol, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,The DDDs are based on prophylaxis.,M04AB01,probenecid,NA,1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,The DDDs are based on prophylaxis.,M04AB02,sulfinpyrazone,NA,0.3,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,The DDDs are based on prophylaxis.,M04AB03,benzbromarone,NA,0.1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,The DDDs are based on prophylaxis.,M04AB04,isobromindione,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,The DDDs are based on prophylaxis.,M04AB05,lesinurad,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AC,Preparations with no effect on uric acid metabolism,The DDDs are based on prophylaxis.,M04AC01,colchicine,NA,1,1,NA,mg,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AC,Preparations with no effect on uric acid metabolism,The DDDs are based on prophylaxis.,M04AC02,cinchophen,NA,1,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AC,Preparations with no effect on uric acid metabolism,The DDDs are based on prophylaxis.,M04AC51,colchicine and probenecid,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AX,Other antigout preparations,The DDDs are based on prophylaxis.,M04AX01,urate oxidase,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AX,Other antigout preparations,The DDDs are based on prophylaxis.,M04AX02,pegloticase,NA,NA,0.57,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA01,etidronic acid,course dose,NA,1.5,NA,NA,g,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA01,etidronic acid,NA,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA02,clodronic acid,course dose,NA,1.5,NA,NA,g,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA02,clodronic acid,NA,1.6,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA03,pamidronic acid,course dose,NA,60,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA04,alendronic acid,NA,10,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA05,tiludronic acid,NA,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA06,ibandronic acid,course dose,NA,6,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA06,ibandronic acid,NA,5,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA07,risedronic acid,NA,5,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonates,"The DDDs for the bisphosphonates are based on the treatment of osteoporosis if this is an approved indication.The DDDs for clodronic acid, pamidronic acid, zoledronic acid, parenteral etidronic acid and parenteral ibandronic acid are based on tumor induced hypercalcemia. The oral DDD for ibandronic acid is based on osteoporosis.  Since the duration of the intravenous treatment courses with the bisphosphonates are varying, from 1-5 days, the DDDs for these parenteral formulations are assigned according to the total course dose.  The DDDs for the oral formulations, which are mainly used for maintenance therapy, are assigned according to daily dosages.The DDD for tiludronic acid is based on the treatment of Pagets disease.",M05BA08,zoledronic acid,course dose,NA,4,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB01,"etidronic acid and calcium, sequential",Refers to etidronic acid,0.4,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB02,"risedronic acid and calcium, sequential",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB03,alendronic acid and colecalciferol,Refers to alendronic acid,10,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB04,"risedronic acid, calcium and colecalciferol, sequential",Refers to risedronic acid,5,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB05,"alendronic acid, calcium and colecalciferol, sequential",Refers to alendronic acid,10,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB06,"alendronic acid and alfacalcidol, sequential",Refers to alendronic acid,10,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB07,risedronic acid and colecalciferol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB08,"zoledronic acid, calcium and colecalciferol, sequential",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BB,"Bisphosphonates, combinations",NA,M05BB09,ibandronic acid and colecalciferol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BC,Bone morphogenetic proteins,NA,M05BC01,dibotermin alfa,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BC,Bone morphogenetic proteins,NA,M05BC02,eptotermin alfa,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX01,ipriflavone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX02,aluminium chlorohydrate,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX03,strontium ranelate,NA,2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX04,denosumab,NA,NA,0.33,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX05,burosumab,NA,NA,2.5,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX06,romosozumab,NA,NA,7,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX07,vosoritide,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX08,menatetrenone,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization,The DDD for denosumab is based on the treatment of osteoporosis.,M05BX53,strontium ranelate and colecalciferol,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AA,Quinine and derivatives,NA,M09AA01,hydroquinine,NA,0.2,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AA,Quinine and derivatives,NA,M09AA72,"quinine, combinations with psycholeptics",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB,Enzymes,NA,M09AB01,chymopapain,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB,Enzymes,NA,M09AB02,collagenase clostridium histolyticum,NA,NA,0.9,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB,Enzymes,NA,M09AB03,bromelains,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB,Enzymes,NA,M09AB52,"trypsin, combinations",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX01,hyaluronic acid,intraarticular,NA,3.6,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX02,"chondrocytes, autologous",NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX03,ataluren,NA,2.8,NA,NA,g,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX04,drisapersen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX05,aceneuramic acid,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX06,eteplirsen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX07,nusinersen,NA,NA,0.1,NA,NA,mg,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX08,golodirsen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX09,onasemnogene abeparvovec,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX10,risdiplam,NA,5,NA,NA,mg,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX11,palovarotene,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX12,viltolarsen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX13,casimersen,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX14,givinostat,NA,NA,NA,NA,NA,NA,NA
M,MUSCULO-SKELETAL SYSTEM,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AX,Other drugs for disorders of the musculo-skeletal system,The DDD for hyaluronic acid is based on intraarticular treatment of arthritis.  The DDD is assigned according to daily dose even if the product is given as weekly injections.,M09AX15,delandistrogene moxeparvovec,NA,NA,NA,NA,NA,NA,NA
